MEDICINA
Departamento
University of Cape Town
Rondebosch, SudáfricaPublicaciones en colaboración con investigadores/as de University of Cape Town (1)
2017
-
Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study
The Lancet HIV, Vol. 4, Núm. 12, pp. e536-e546